Tesla
TSLA
NVIDIA
NVDA
Palantir
PLTR
4
Apple
AAPL
5
Strategy
MSTR
US Stock MarketDetailed Quotes
BMEZ Blackrock Health Sciences Trust II
- 15.215
- -0.105-0.69%
Trading Mar 11 10:07 ET
1.58BMarket Cap72.45P/E (TTM)
15.380High15.200Low60.43KVolume15.355Open15.320Pre Close924.05KTurnover0.06%Turnover Ratio72.45P/E (Static)103.85MShares16.56552wk High2.06P/B1.58BFloat Cap12.90652wk Low1.78Dividend TTM103.85MShs Float21.076Historical High11.69%Div YieldTTM1.18%Amplitude8.191Historical Low15.292Avg Price1Lot Size
Blackrock Health Sciences Trust II Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2024 | (FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | |
|---|---|---|---|---|---|
| Operating cash flow (Indirect Method) | |||||
| Cash flow from continuing operating activities | |||||
| Net income from continuing operations | -66.00%23.75M | 110.23%69.86M | -137.18%-682.72M | -121.96%-287.85M | --1.31B |
| Change in working capital | -116.77%-1.65M | 344.93%9.83M | 22.61%-4.01M | -139.95%-5.18M | --12.98M |
| -Change in receivables | 194.48%324.64K | -46.59%-343.6K | -77.77%-234.41K | 79.53%-131.86K | ---644.04K |
| -Change in prepaid assets | 146.46%7.51K | -133.41%-16.16K | 271.81%48.37K | -39.26%-28.16K | ---20.22K |
| -Change in other current assets | --0 | --0 | --0 | --0 | --0 |
| -Change in other current liabilities | -119.79%-2.07M | 436.61%10.47M | 32.92%-3.11M | -148.42%-4.64M | --9.58M |
| Cash from discontinued operating activities | |||||
| Operating cash flow | 18.87%267.2M | -6.92%224.79M | 27.32%241.5M | 108.81%189.68M | ---2.15B |
| Investing cash flow | |||||
| Cash flow from continuing investing activities | |||||
| Cash from discontinued investing activities | |||||
| Financing cash flow | |||||
| Cash flow from continuing financing activities | |||||
| Net issuance payments of debt | -248.49%-291.88K | 106.23%196.57K | 146.39%95.31K | -200.00%-205.46K | --205.46K |
| Net commonstock issuance | -75.29%-89.46M | -14.15%-51.04M | ---44.71M | --0 | --2.25B |
| Cash dividends paid | -2.45%-177.78M | 11.92%-173.52M | -3.37%-197M | -92.31%-190.59M | ---99.1M |
| Net other financing activities | --0 | --0 | --0 | --0 | --0 |
| Cash from discontinued financing activities | |||||
| Financing cash flow | -19.24%-267.53M | 7.14%-224.37M | -26.64%-241.62M | -108.86%-190.79M | --2.15B |
| Net cash flow | |||||
| Beginning cash position | 1,165.87%457.17K | -76.83%36.12K | -87.67%155.88K | 1,164.01%1.26M | --100K |
| Current changes in cash | -178.13%-328.97K | 451.59%421.04K | 89.19%-119.75K | -195.20%-1.11M | --1.16M |
| Effect of exchange rate changes | -393.75%-47 | 200.00%16 | 0.00%-16 | -150.00%-16 | --32 |
| End cash position | -71.97%128.15K | 1,165.87%457.17K | -76.83%36.12K | -87.67%155.88K | --1.26M |
| Free cash flow | 18.87%267.2M | -6.92%224.79M | 27.32%241.5M | 108.81%189.68M | ---2.15B |
| Currency Unit | USD | USD | USD | USD | USD |
| Audit Opinions | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion | Unqualified Opinion |